Menu

Tag: FDA

10/22/18   |   By

Nootropics: How Safe Are They, Exactly?

In a competitive workforce and academic sphere, employees and students are more desperate than ever to gain an edge on the competition. Several believe that nootropics — drugs specifically designed […]

Read More
06/10/10   |   By

FDA Warns Pfizer on failure to report drug complaints. | DC Metro Area Medical Malpractice Law Blog

Posted by: Salvatore J. Zambri, founding partner According to an AP report, the Food and Drug Administration issued a warning letter to “Pfizer I

Read More
04/22/10   |   By

Sedative Vials Too Large, Doctor Testifies | DC Metro Area Medical Malpractice Law Blog

Posted by: Salvatore J. Zambri, founding partner

Read More
05/11/09   |   By

FDA Too Lenient On Device Approval | DC Metro Area Medical Malpractice Law Blog

Posted by: Salvatore J. Zambri, Esquire An editorial from yesterday’s New York Times challenges the Food and Drug Administration (FDA), suggesting that the agency has been too lenient in approving […]

Read More
04/28/09   |   By

FDA Meets To Discuss Device Approval | DC Metro Area Medical Malpractice Law Blog

Posted by: Salvatore J. Zambri, Esquire The New York Times reported recently that the Food and Drug Administration (FDA) will conduct a rare meeting to discuss its device division, which […]

Read More

Archives

Schedule a Free Consultation

Have you or your loved one sustained injuries in Washington DC, Maryland or Virginia? Regan Zambri Long PLLC has the best lawyers in the country to analyze your case and answer the questions you may have.

Call 202-960-4596

  • Please do not send any confidential or sensitive information in this form. This form sends information by non-encrypted email, which is not secure. Submitting this form does not create an attorney-client relationship.

  • This field is for validation purposes and should be left unchanged.

Back to Top